Cyclophosphamide-induced atrial fibrillation in the context of ANCA-associated vasculitis: a case report
The cardiotoxic manifestation of cyclophosphamide can arise from its use in several immune-mediated conditions. Given its potential for cardiotoxicity, careful cardiac monitoring during and after cyclophosphamide infusion is essential to ensure timely intervention, if needed.
Authors
- Sarmila Dhakal (ORCID: https://orcid.org/0000-0002-5440-9085)
- R Shakya (ORCID: https://orcid.org/0000-0001-7345-5362)
- Roshan Kumar Singh (ORCID: https://orcid.org/0000-0002-3382-9515)
- Sagar Bhandari (ORCID: https://orcid.org/0000-0003-1007-9034)
- Aayusha Dhakal
- Srijan Shailesh Pandey
Institutions
- Nepal Medical College Teaching Hospital (NP)
- SUNY Downstate Health Sciences University (US)
- Lyceum-Northwestern University (PH)
- Kathmandu University (NP)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1097/ms9.0000000000002809
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.42